JPS4949984A - - Google Patents

Info

Publication number
JPS4949984A
JPS4949984A JP48067291A JP6729173A JPS4949984A JP S4949984 A JPS4949984 A JP S4949984A JP 48067291 A JP48067291 A JP 48067291A JP 6729173 A JP6729173 A JP 6729173A JP S4949984 A JPS4949984 A JP S4949984A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP48067291A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed filed Critical
Publication of JPS4949984A publication Critical patent/JPS4949984A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
JP48067291A 1972-06-14 1973-06-14 Pending JPS4949984A (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins
US35956773A 1973-05-11 1973-05-11

Publications (1)

Publication Number Publication Date
JPS4949984A true JPS4949984A (cs) 1974-05-15

Family

ID=27401552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48067291A Pending JPS4949984A (cs) 1972-06-14 1973-06-14

Country Status (10)

Country Link
JP (1) JPS4949984A (cs)
AU (1) AU474443B2 (cs)
CA (1) CA999574A (cs)
CH (1) CH585228A5 (cs)
DE (1) DE2330307C2 (cs)
ES (1) ES415874A1 (cs)
FR (1) FR2187305B1 (cs)
GB (1) GB1416503A (cs)
IE (1) IE37793B1 (cs)
NL (1) NL7308199A (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2539664A1 (de) * 1974-09-06 1976-03-18 Sumitomo Chemical Co Cephalosporin-derivate
JPS51138694A (en) * 1975-03-27 1976-11-30 Pfizer Production of cephalosporin derivative
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215942B1 (cs) * 1973-01-31 1978-12-22 Bristol Myers Co
AR207752A1 (es) 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
US20110287112A1 (en) 2009-01-30 2011-11-24 Ono Pharmaceutical Co., Ltd. Prostate cancer progression inhibitor and progression inhibition method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2539664A1 (de) * 1974-09-06 1976-03-18 Sumitomo Chemical Co Cephalosporin-derivate
JPS51138694A (en) * 1975-03-27 1976-11-30 Pfizer Production of cephalosporin derivative
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents

Also Published As

Publication number Publication date
CA999574A (en) 1976-11-09
DE2330307C2 (de) 1983-03-10
DE2330307A1 (de) 1974-01-03
IE37793L (en) 1973-12-14
CH585228A5 (cs) 1977-02-28
NL7308199A (cs) 1973-12-18
AU474443B2 (en) 1976-07-22
AU5695273A (en) 1974-12-19
IE37793B1 (en) 1977-10-12
ES415874A1 (es) 1976-02-01
FR2187305B1 (cs) 1976-12-03
FR2187305A1 (cs) 1974-01-18
GB1416503A (en) 1975-12-03

Similar Documents

Publication Publication Date Title
DK142913C (cs)
FR2187305B1 (cs)
JPS518750B2 (cs)
JPS5136929B2 (cs)
JPS5138207B2 (cs)
JPS4978520U (cs)
JPS4986223U (cs)
CH580076A5 (cs)
CH578029A5 (cs)
CH587476A5 (cs)
CH587057A5 (cs)
CH586937A5 (cs)
CH585676A5 (cs)
CH585669A5 (cs)
CH585261A5 (cs)
CH585199A5 (cs)
CH584788A5 (cs)
CH583557A5 (cs)
CH581640A5 (cs)
CH581609A5 (cs)
CH581092A5 (cs)
CH580908A5 (cs)
CH579443A5 (cs)
CH578418A5 (cs)
CH578348A5 (cs)